Publications by authors named "R Singla"

Furan (C₄H₄O), an unintended hazardous compound, is formed in various thermally processed foods through multiple pathways, raising concerns due to its potential carcinogenicity in humans. The aim of this comprehensive review was to synthesize and evaluate the latest research on furan, from its formation by different precursors to its presence in diverse food matrices, as well as the emerging methods for its detection and mitigation. Emphasizing the toxicity of furan, it explored evidence from in vitro and in vivo studies, including reproductive toxicity, carcinogenic effects, and related biomarkers.

View Article and Find Full Text PDF

Malaria kills millions of people annually, and it is one of the major causes of preventable mortality in the world. Of the different plasmodium species that induce malaria, Plasmodium falciparum and Plasmodium vivax account for the most severe form of malarial disease in humans. This review focuses on understanding preventive measures, mutation-based disease evolution, malaria-related biomarkers, and potential plant bioactive components for the treatment and management of malaria.

View Article and Find Full Text PDF

Background: Due to the lack of a comprehensive pharmacology test set, evaluating the potential and value of large language models (LLMs) in pharmacology is complex and challenging.

Aims: This study aims to provide a test set reference for assessing the application potential of both general-purpose and specialized LLMs in pharmacology.

Methods: We constructed a pharmacology test set consisting of three tasks: drug information retrieval, lead compound structure optimization, and research trend summarization and analysis.

View Article and Find Full Text PDF

The literature review suggested that the audio signal-modified shuttle walk test (SWTSR) was equally reliable and valid when compared to the conventional shuttle walk test. A comparison of SWTSR with the six-minute walk test (6MWT), which is considered the gold standard in walk tests, allowed us to evaluate the SWTSR and determine its validity and reliability as an alternative or supplement to the 6MWT. The objective of this study was to determine the correlation between the distances walked during a SWTSR and the 6MWT in healthy, normal adults.

View Article and Find Full Text PDF
Article Synopsis
  • The glucagon receptor antagonist volagidemab is a novel monoclonal antibody that helps manage type-1 diabetes (T1D) by lowering insulin needs and reducing risks like diabetic ketoacidosis.
  • A systematic review of three randomized controlled trials (98 patients) found that volagidemab significantly decreased the total daily dose of insulin and average blood glucose levels compared to a placebo.
  • Additionally, while it increased the time patients spent within the target blood glucose range, there was no significant change in the occurrence of adverse events or hypoglycemia when compared to the placebo group.
View Article and Find Full Text PDF